NASDAQ | TSX: ACB
Balance Sheet Remains in Net Cash Position,
Further Strengthened with Accretive Debt Reduction
EDMONTON, AB, Dec. 5, 2022
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora")
(NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future
of cannabinoids worldwide, today announced that it has
repurchased an aggregate of approximately $102.5 million (US$76.1
million) principal amount of its convertible senior notes
("Notes") at a total cost, including accrued interest, of
$99.4 million (US$73.8 million) in cash. Following completion of
this repurchase, Aurora will have approximately $148 million (US$110
million) of Notes outstanding.
The purpose of the transaction, which represents a repurchase of
a portion of the Notes at a 4.5% discount to par value, was to
reduce the Company's debt and annual cash interest costs. Aurora
has repurchased an aggregate of approximately $316.5 million (US$235
million) principal amount of its convertible senior notes
over the last twelve months, resulting in annual cash interest
savings of approximately $17.4
million (US$12.9 million).
Aurora's balance sheet remains amongst the strongest in the
industry, and the Company reiterates its expectation of achieving
Adjusted EBITDA Profitability by December
31, 2022.
This announcement does not constitute an offer to sell, or a
solicitation of an offer to buy, any security and shall not
constitute an offer, solicitation or sale in any jurisdiction in
which such offering would be unlawful.
About Aurora
Aurora is a global leader in the cannabis industry, serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as
well as CBD brands, Reliva and KG7. Medical
cannabis brands include MedReleaf, CanniMed, Aurora and
Whistler Medical Marijuana Co. Aurora also has a controlling
interest in Bevo Farms, North
America's leading supplier of propagated agricultural
plants. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and adult recreational markets wherever they are launched. Learn
more at www.auroramj.com and follow us on Twitter and
LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under
the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements regarding the
purpose of the debt repurchase and the Company's path and timing to
achieve Adjusted EBITDA profitability.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations, management's estimation that SG&A will grow only in
proportion of revenue growth, the ability to expand and maintain
distribution capabilities, the impact of competition, the general
impact of financial market conditions, the yield from cannabis
growing operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out under
the heading "Risk Factors" in the Company's annual information form
dated September 30, 2022 (the "AIF")
and filed with Canadian securities regulators available on the
Company's issuer profile on SEDAR at www.sedar.com and filed with
and available on the SEC's website at www.sec.gov. The Company
cautions that the list of risks, uncertainties and other factors
described in the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-repurchases-103-million-principal-amount-of-convertible-notes-balance-sheet-among-strongest-in-industry-301694037.html
SOURCE Aurora Cannabis Inc.